Clinical trial
The Use of Glycaemic Response to Sulphonylureas as a Tool to Investigate Type 2 Diabetes Pathophysiology
NCT00738088 is registered in ClinicalTrials.gov with NHS Tayside as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Glycaemic Response to Sulphonylureas as a Tool to Investigate Type 2 Diabetes Pathophysiology
- Lead sponsor
- NHS Tayside
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 30, 2007
- Completion date
- March 3, 2011
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.